Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

robina-weermeijer-3kgf9r_0ohs-unsplash_2

Biogen announces licensing of Denali’s ATV to target Amyloid Beta

April 13, 2023 Research and Development

Biogen and Denali Therapeutics have announced that Biogen has exercised its option to license Denali’s Antibody Transport Vehicle: Amyloid beta …
News
minku-kang-acnintiifd8-unsplash_1

Aspect Biosystems and Novo Nordisk partner with $75m deal to develop bioprinted tissue therapeutics

April 13, 2023 Research and Development

Canadian biotech company Aspect Biosystems and Denmark-based Novo Nordisk have announced a collaboration, development and license agreement to develop bioprinted …
News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna announces mixed success clinical updates for mRNA pipeline

April 12, 2023 Research and Development

Biotechnology company Moderna has announced clinical updates detailing the expansion and advancement of its mRNA pipeline, which includes treatments for …
News
christina-victoria-craft-zhys6xn7sue-unsplash_5

Molecular Templates announces hold for phase 1 study

April 11, 2023 Research and Development

Molecular Templates has announced that the FDA has placed a partial hold on its phase 1 study for MT-0169 based …
News
chuttersnap-oijvdm3zx4i-unsplash

Synapse receives FDA approval for its NeuRx DPS to treat patients with stable SCI

April 6, 2023 Research and Development

Synapse Biomedical has announced that it has gained premarket approval (PMA) from the FDA for its NeuRxDiaphragm Pacing System (NeuRx …
News
brano-mm1vipqd0oa-unsplash

Vertex Pharmaceuticals and CRISPR Therapeutics submit FDA rolling Biologics License Applications for gene editing-based medicine

April 4, 2023 Research and Development

US-based Vertex Pharmaceuticals and Swiss CRISPR Therapeutics have announced the completion of their rolling Biologics License Applications (BLAs) to the …
News
ed-us-k0dml4nmopo-unsplash

aVaxziPen announces positive data for multiple diseases with novel needle-free vaccine

April 3, 2023 Research and Development

aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will …
News

Janssen reports new Rybrevant data for patients with advanced non-small cell lung cancer

March 30, 2023 Research and Development

Janssen, part of Johnson & Johnson, has announce new long-term data from its CHRYSALIS study, which assessed Rybrevant (amivantamab) in …
News

Netris Pharma doses first patient in pancreatic cancer study

March 29, 2023 Research and Development

Netris Pharma has announced that it has dosed its first patient in the Lap-NET1 study for the safety and efficacy …
News

AbbVie’s upadacitinib meets primary endpoint in trial for systemic lupus erythematosus

March 29, 2023 Research and Development

AbbVie has shared that upadacitinib (Rinvoq) has been shown to be effective in treating patients with moderately-to-severely-active systemic lupus erythematosus …
News

Novo Nordisk announces results from phase 3 PIONEER PLUS trial

March 28, 2023 Research and Development

Novo Nordisk has announced headline results from the phase 3b PIONEER PLUS trial for the safety and efficacy of once-daily …
News

GSK shares promising clinical trial results for endometrial cancer therapy

March 28, 2023 Research and Development

GSK has announced promising results from part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) alongside standard-of-care chemotherapy …
News

Novartis announces positive results from phase 3 trial of Kisqali for early breast cancer

March 27, 2023 Research and Development

Novartis has announced positive results from its phase 3 NATALEE trial assessing Kisqali (ribociclib) along with endocrine therapy (ET) in …
News

Biogen shares FDA decisions on ALS drug

March 23, 2023 Research and Development

US-based Biogen has announced two decisions the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee made surrounding its ALS …
News

Kite’s Yescarta CAR T-cell therapy shows statistically significant improvement in overall survival

March 22, 2023 Research and Development

Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026